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and §John R. Raymond
Department of Oral Biology, University of Nebraska Medical Center; †Department of Biological Sciences, University of
Nebraska, Lincoln, Nebraska; *Mayo Clinic at Jacksonville, Florida; ‡Department of Biology, Walter Reed Army Institute of
Research, Washington, D.C.; and §Department of Medicine, Medical University of South Carolina,
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Abstract: The present study underlines the importance of
p21ras in regulating the inducible nitric oxide synthase
(iNOS) in primary astrocytes. Bacterial lipopolysaccharides induced the GTP loading of p21ras, and the expression of a dominant-negative mutant of p21ras (⌬p21ras)
inhibited lipopolysaccharide-induced GTP loading in rat
primary astrocytes. To delineate the role of p21ras in the
induction of iNOS, we examined the effect of ⌬p21ras on
the expression of iNOS and the production of nitric oxide.
It is interesting that expression of ⌬p21ras markedly inhibited the production of nitric oxide and the expression
of iNOS in lipopolysaccharide- and proinflammatory cytokine (tumor necrosis factor-␣, interleukin-1␤; interferon-␥)-stimulated rat and human primary astrocytes. Inhibition of iNOS promoter-derived chloramphenicol acetyltransferase activity by ⌬p21ras suggests that p21ras is
involved in the transcription of iNOS. As activation of
nuclear factor-B (NF-B) is necessary for the transcription of iNOS, we examined the effect of ⌬p21ras on the
activation of NF-B. Expression of ⌬p21ras inhibited the
DNA binding as well as the transcriptional activity of NF-B
in activated astrocytes, suggesting that ⌬p21ras inhibits the
expression of iNOS by inhibiting the activation of NF-B.
These studies also suggest that inhibitors of p21ras may be
used as therapeutics in nitric oxide- and cytokine-mediated
neuroinflammatory diseases. Key Words: Astrocytes—
Cytokines—Lipopolysaccharides—p21ras—Inducible nitric
oxide synthase—Nuclear factor-B.
J. Neurochem. 74, 2288 –2295 (2000).

of the inducible isoform (iNOS), expressed in response
to different stimuli in various cell types including macrophages, hepatocytes, and neutrophils, is independent of
calcium (Xie et al., 1992; Vos et al., 1999). Glial cells in
the CNS like astrocytes and microglia have also been
shown to induce iNOS in response to a series of proinflammatory cytokines including interleukin-1␤ (IL-1␤),
tumor necrosis factor-␣ (TNF-␣), interferon-␥ (IFN-␥),
and bacterial lipopolysaccharide (LPS) (Simmons and
Murphy, 1992; Zielasek et al., 1992; Lee et al., 1993;
Pahan et al., 1997b). NO derived from the activation of
iNOS in astrocytes and microglia under the influence of
proinflamatory cytokines is assumed to contribute to
oligodendrocyte degeneration in demyelinating diseases
and neuronal death during ischemic and traumatic brain
injury (Koprowski et al., 1993; Merrill et al., 1993; Cross
et al., 1994; Endoh et al., 1994).
Therefore, characterization of intracellular pathways
evoked to transduce the signal from the cell surface to the
nucleus for the induction of iNOS in activated glial cells
is an active area of investigation. Identification of the
DNA-binding site for nuclear factor-B (NF-B), a
proinflammatory transcription factor, in the promoter
region of iNOS (Xie et al., 1994), and inhibition of iNOS
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Nitric oxide (NO), a vascular and neuronal messenger
and a cytotoxic and cytostatic agent, is synthesized from
L-arginine by the enzyme nitric oxide synthase (NOS)
(Nathan, 1992). Basically, NOS is classified into two
groups. One type, constitutively expressed (cNOS) in
several cell types (e.g., neurons, endothelial cells), is
regulated predominantly at the posttranscriptional level
by calmodulin in a calcium-dependent manner (Nathan,
1992; Jaffrey and Snyder, 1995). In contrast, the activity
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expression by inhibitors of NF-B activation (Nishiya
et al., 1995; Pahan et al., 1997a,b, 1998a) have established an essential role of NF-B activation in the induction of iNOS. Suppression of NF-B activation and
inhibition of iNOS expression by inhibitors of tyrosine
kinase in glial cells suggest the possible involvement of
tyrosine phosphorylation in the activation of NF-B and
the induction of iNOS (Nishiya et al., 1995). Recently,
we have found that inhibitors of the mevalonate pathway
(lovastatin and sodium phenylacetate) inhibit the expression of iNOS and the activation of NF-B in activated
glial cells (Pahan et al., 1997b). Inhibition of LPS-induced expression of iNOS and activation of NF-B in rat
primary astrocytes by sodium phenylacetate and its reversal by farnesyl pyrophosphate, but not by mevalonate
(Pahan et al., 1997b), indicate that the farnesylation
reaction is involved in the activation of NF-B and the
induction of iNOS. As farnesylation is a necessary step
for the activation of p21ras, the inhibition of expression
of iNOS and activation of NF-B by mevalonate inhibitors suggested a possible role of p21ras in these proinflammatory processes.
The present study was undertaken to investigate the
cellular regulation of the induction of iNOS and the
activation of NF-B by p21ras in rat and human primary
astrocytes. We herein report that the activation of NF-B
and the induction of iNOS in rat and human primary
astrocytes are uniquely sensitive to the knockdown of
p21ras by the expression of a dominant-negative mutant
of p21ras, suggesting that the activation of p21ras may be
an important target for therapeutic intervention in neuroinflammatory diseases.
MATERIALS AND METHODS
Reagents
Fetal bovine serum (FBS), Dulbecco’s modified Eagle’s
medium (DMEM)/F-12, Hanks’ balanced salt solution (HBSS),
and NF-B DNA binding protein detection kit were from Life
Technologies, Inc. (U.S.A.). LPS (Escherichia coli, serotype
(111:B4) was from Sigma. Antibodies against p21ras and antibodies against mouse macrophage iNOS were obtained from
Transduction Laboratories (U.S.A.). Rat and human recombinant
TNF-␣, IL-1␤, and IFN-␥ were obtained from R&D (U.S.A.).
[␥-32P]ATP (3,000 Ci/mmol) and trisodium [32P]orthophosphate
(200 mCi/mmol) were purchased from ICN (U.S.A.).

Preparation of rat astrocytes
Rat primary astrocytes were prepared from rat cerebral tissue as described by McCarthy and de Vellis (1980). Cells were
maintained in DMEM/F-12 medium containing 10% FBS. After 10 days of culture, astrocytes were separated from microglia
and oligodendrocytes by shaking for 24 h in an orbital shaker
at 240 rpm. To ensure the removal of oligodendrocytes and
microglia, the shaking was repeated twice after a gap of 1 or 2
days. By immunofluorescence assay, these cultures homogeneously expressed glial fibrillary acidic protein, the definitive
marker for astrocytes. Cells were trypsinized, subcultured, and
stimulated with LPS or different cytokines in serum-free
DMEM/F-12 medium.
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Preparation of human astrocytes
Fetal CNS tissue was obtained from the Human Embryology
Laboratory (University of Washington, Seattle, WA, U.S.A.).
The CNS tissue from each fetal specimen was processed separately and independently, as were subsequent cell cultures;
there was no pooling of CNS tissue from distinct fetal specimens. These cells were grown in a serum-free, defined medium
(B16) enriched with 5 ng/ml basic fibroblast growth factor for
optimal growth of astrocytes and for the suppression of fibroblast growth (McCarthy et al., 1995). By immunofluorescence
assay, these cultures homogeneously expressed glial fibrillary
acidic protein. Cells were trypsinized, subcultured, and stimulated with LPS or different cytokines in serum-free DMEM/
F-12 medium.

Expression of ⌬p21ras in astrocytes

In the dominant-negative form of p21ras (⌬p21ras), the Ser
residue at position 17 was changed to Asn (S17N mutant). This
mutant binds preferentially to GDP and acts as the dominant
inhibitor of p21ras function presumably by blocking access to
exchange factors (Qiu et al., 1995; Garnovskaya et al., 1996).
The engineering of the construct and description of the vector
driving the expression of the proteins have been published
previously (Garnovskaya et al., 1996). Rat and human primary
astrocytes were transiently transfected with either ⌬p21ras or an
empty vector by Lipotaxi (Stratagene) following the manufacturer’s protocol. In brief, for transfection of each well of a
six-well plate, 2 g of DNA was allowed to form a complex
with 20 l of Lipotaxi and serum-free DMEM/F-12 in a total
volume of 300 l by incubating at room temperature in a sterile
Eppendorf for 30 min. In the meantime, the cell monolayer
(50 – 60% confluent) was washed twice with HBSS and replenished with 450 l of serum-free DMEM/F-12. Then the entire
mixture of Lipotaxi, DMEM/F-12, and DNA was added dropwise to the cells while swirling. After an incubation of 6 h, 750
l of DMEM/F-12 containing 20% FBS was added to a total
volume of 1.5 ml and cells were incubated further for 24 h. For
transfection of cells in 60-mm dishes, 4 g of DNA was
complexed with 50 l of Lipotaxi, whereas for cells in 100-mm
dishes, 8 g of DNA was complexed with 150 l of Lipotaxi.
During cotransfection in six-well plates, 2 g of either ⌬p21ras
or the empty vector and 1 g of the other DNA were complexed together with 30 l of Lipotaxi. After transfection, cells
were stimulated with different stimuli for the indicated time
periods under serum-free conditions. To monitor the transfection efficiency, cells were cotransfected with a pCAT 3-control
plasmid (Promega, Madison, WI, U.S.A.). A radioisotopic
method was used to assay chloramphenicol acetyltransferase
(CAT) activity using a kit (Promega) as described by the
manufacturer’s protocol (Pahan et al., 1998b, 1999). As revealed by the CAT assay, transfection efficiency ranged between 38 and 54%.

Assay of p21ras activation
Activation of p21ras was assayed by GTP loading as described by Downward et al. (1990) with slight modifications. In
brief, cells were labeled with [32P]orthophosphate in phosphate-free medium for 16 h and incubated with different stimuli
under serum-free conditions. At various points of stimulation,
cells were lysed with ice-cold lysis buffer containing 1% (vol/
vol) Nonidet P-40, 100 mM NaCl, 20 mM Tris, pH 7.4, 10 mM
iodoacetamide, 10 mM NaF, 1 mM sodium orthovanadate, 1
mM phenylmethylsulfonyl fluoride (PMSF), 1 g/ml leupeptin,
1 g/ml antipain, 1 g/ml aprotinin, and 1 g/ml pepstatin A.
Lysates were precleared with protein G-Sepharose beads (Phar-
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macia Biotech Inc.) for 1 h at 4°C, followed by the addition of
2 g/ml p21ras antibody. After 2 h of incubation at 4°C, protein
G-Sepharose beads were added and the resulting mixture was
further incubated for 1 h at 4°C. The immunoprecipitates were
washed three times with 20 mM Tris, pH 7.4, 500 mM NaCl, 5
mM MgCl2, 0.1% Triton X-100, and 0.005% sodium dodecyl
sulfate (SDS). Nucleotides (GTP and GDP) associated with ras
were eluted with 2 mM EDTA, 2 mM dithiothreitol (DTT),
0.2% SDS, 0.5 mM GTP, 0.5 mM GDP at 68°C for 20 min
(Downward et al., 1990). The eluted nucleotides were separated
on polyethylenimine TLC plates using 0.75 M KH2PO4, pH
3.4, as a solvent and exposed to x-ray film.

Assay for NO synthesis
Synthesis of NO was determined by assay of culture supernatants for nitrite, a stable reaction product of NO with molecular oxygen. In brief, 400 l of culture supernatant was allowed
to react with 200 l of Griess reagent (Green et al., 1982;
Pahan et al., 1997a) and incubated at room temperature for 15
min. The optical density of the assay samples was measured
spectrophotometrically at 570 nm. Fresh culture medium
served as the blank in all experiments. Nitrite concentrations
were calculated from a standard curve derived from the reaction of NaNO2 in the assay. Protein was measured by the
procedure of Bradford (1976).

Immunoblot analysis for iNOS
Following 24 h of incubation in the presence or absence of
different stimuli, cells were scraped off, washed with HBSS,
and homogenized in 50 mM Tris-HCl, pH 7.4, containing
protease inhibitors (1 mM PMSF, 5 g/ml aprotinin, 5 g/ml
pepstatin A, and 5 g/ml leupeptin). After electrophoresis, the
proteins were transferred onto a nitrocellulose membrane, and
the iNOS band was visualized by immunoblotting with antibodies against mouse macrophage iNOS and 125I-labeled protein A (Pahan et al., 1997a, 1998a).

RNA isolation and northern blot analysis
Cells were taken out from culture dishes directly by adding
Ultraspec-II RNA reagent (Biotecx Laboratories Inc.), and total
RNA was isolated according to the manufacturer’s protocol.
For northern blot analyses, 20 g of total RNA was electrophoresed on 1.2% denaturing formaldehyde-agarose gels, electrotransferred to Hybond-nylon membrane (Amersham), and
hybridized at 68°C with 32P-labeled cDNA probe using Express Hyb hybridization solution (Clontech) as described by the
manufacturer. The cDNA fragment for iNOS was amplified by
PCR using two primers (forward primer: 5⬘-CTC CTT CAA
AGA GGC AAA AAT A-3⬘; reverse primer: 5⬘-CAC TTC
CTC CAG GAT GTT GT-3⬘) and cloned in pGEM-T vector
(Geller et al., 1993; Pahan et al., 1997a, 1998a). The clone was
confirmed by DNA sequencing, and the insert was used as
probe. After hybridization, filters were washed two or three
times in solution I (2⫻ saline–sodium citrate, 0.05% SDS) for
1 h at room temperature, followed by solution II (0.1⫻ saline–
sodium citrate, 0.1% SDS) at 50°C for another hour. The
membranes were then dried and exposed to x-ray films (Kodak).
The same filters were stripped and rehybridized with probes for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), or the
same amount of RNA was electrophoresed and hybridized for
GAPDH.

Construction of reporter plasmid, transfection, and
assay of CAT activity
The CAT under the control of iNOS promoter was created
by subcloning the 1.5-kb promoter from pGEM-NOS at SphI
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and SalI restriction sites of pCAT-basic vector (Promega) (Pahan et al., 1998b, 1999). Full-length promoter (Eberhardt et al.,
1996) was amplified by using two primers (forward: 5⬘-GAG
AGT GTG CAA GTA TTT GTA GGA G-3⬘; reverse: 5⬘-AAG
GTG GCT GAG AAG TTT CA-3⬘) from rat genomic DNA
and cloned in pGEM-T vector (Promega) to produce pGEMNOS. The clone was confirmed by restriction mapping and
sequencing. The cells were transfected with reporter plasmid by
using the Lipotaxi (Stratagene) method, as described in the
manufacturer’s protocol. Twenty-four hours after transfection,
cells were treated with different stimuli for 14 h and harvested.
A radioisotopic method was used to assay CAT activity using
a kit (Promega) as described by the manufacturer’s protocol.

Preparation of nuclear extracts and electrophoretic
mobility shift assay (EMSA)
Nuclear extracts from stimulated or unstimulated astrocytes
(1 ⫻ 107 cells) were prepared using the method of Dignam
et al. (1983) with slight modification. Cells were harvested,
washed twice with ice-cold phosphate-buffered saline, lysed in
400 l of buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 2 mM
MgCl2, 0.5 mM DTT, 1 mM PMSF, 5 g/ml aprotinin, 5 g/ml
pepstatin A, and 5 g/ml leupeptin) containing 0.1% Nonidet
P-40 for 15 min on ice, vortex-mixed vigorously for 15 s, and
centrifuged at 14,000 rpm for 30 s. The pelleted nuclei were
resuspended in 40 l of buffer B [20 mM HEPES, pH 7.9, 25%
(vol/vol) glycerol, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 0.5 mM DTT, 1 mM PMSF, 5 g/ml aprotinin, 5 g/ml
pepstatin A, and 5 g/ml leupeptin]. After 30 min on ice,
lysates were centrifuged at 14,000 rpm for 10 min. Supernatants containing the nuclear proteins were diluted with 20 l of
modified buffer C [20 mM HEPES, pH 7.9, 20% (vol/vol)
glycerol, 0.05 M KCl, 0.2 mM EDTA, 0.5 mM DTT, and 0.5
mM PMSF] and stored at ⫺70°C until use. Nuclear extracts
were used for the EMSA in 6% nondenaturing polyacrylamide
gel (Pahan et al., 1997a,b) using the NF-B DNA binding
protein detection system kit (GibcoBRL), according to the
manufacturer’s protocol.

Assay of transcriptional activity of NF-B

To assay the transcriptional activity of NF-B, cells were
transfected with pNF-B-Luc, an NF-B-dependent reporter
construct (obtained from Stratagene), using the Lipotaxi
method. Twenty-four hours after transfection, cells were
treated with different stimuli for 5 h. Total cell extracts were
used to measure luciferase activity in a Turner Design luminometer (TD-20/20) using an assay kit from Stratagene (Pahan
et al., 1998b, 1999).

RESULTS
Knockdown of p21ras function by the expression of
⌬p21ras inhibits the expression of iNOS in rat
primary astrocytes
To investigate the involvement of p21ras in the expression of iNOS in glial cells, we inhibited the function of
this small G protein in rat primary astrocytes by a dominant-negative mutant of p21ras (⌬p21ras) in which the
Ser residue at position 17 was changed to Asn (S17N
mutant) (Qiu et al., 1995; Garnovskaya et al., 1996).
First, we examined the effect of expression of ⌬p21ras on
the function of p21ras as measured by GTP loading. LPS
induced GTP loading of p21ras within minutes in rat
primary astrocytes, whereas expression of ⌬p21ras mark-
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(Fig. 3B), suggesting that, similar to LPS, cytokinemediated expression of iNOS also requires the involvement of p21ras.

FIG. 1. Expression of ⌬p21ras inhibits LPS-induced GTP loading
in rat primary astrocytes. Cells plated at 50 – 60% confluence in
60-mm dishes were transfected with 4 g of either an empty
vector (A) or ⌬p21ras (B) using Lipotaxi as described in Materials
and Methods. At 24 h after transfection, cells were labeled with
[32P]orthophosphate for 16 h in phosphate-free medium and
then stimulated with 1 g/ml LPS. At different points of stimulation, cells were lysed with the lysis buffer, lysates were immunoprecipitated with antibodies against p21ras, and nucleotides
(GTP and GDP) released from immunoprecipitates were analyzed by TLC as described in Materials and Methods.

edly inhibited LPS-induced GTP loading (Fig. 1), suggesting that, as in other cell types (Qiu et al., 1995;
Garnovskaya et al., 1996), ⌬p21ras is able to inhibit the
function of p21ras in astrocytes. Then we assessed the
effect of expression of ⌬p21ras on the induction of NO
production in rat primary astrocytes. Figure 2A shows
that ⌬p21ras markedly inhibited the production of NO in
LPS-stimulated primary astrocytes, whereas expression
of the empty vector “dummy” had no effect. To understand the mechanism of this inhibitory effect of ⌬p21ras
on LPS-mediated nitrite production, we examined the
effect of ⌬p21ras on protein and mRNA levels of iNOS.
Western blot analysis with antibodies against murine
macrophage iNOS and northern blot analysis for iNOS
mRNA of LPS-stimulated astrocytes clearly show that
⌬p21ras significantly inhibited the LPS-mediated induction of iNOS protein (Fig. 2B) and mRNA (Fig. 2C).
Farnesyltransferase (FTase) inhibitor I is known to prevent farnesylation of p21ras, thus resulting in its inability
to associate with other signaling components in the cell
(Garcia et al., 1993). To confirm the involvement of
p21ras in the induction of iNOS from a different angle,
we examined the effect of FTase inhibitor I (Calbiochem) on LPS-induced production of NO. About 55%
inhibition of NO production was observed with 50 M
FTase inhibitor I (data not shown), suggesting again the
involvement of p21ras in the induction of NO production.
Similar to LPS, proinflammatory cytokines (TNF-␣, IL1␤, and IFN-␥) are also known to induce the expression
of iNOS in rat primary astrocytes (Nishiya et al., 1995;
Pahan et al., 1997b, 1998a). To examine whether cytokine-induced NO production is also inhibited by the
expression of ⌬p21ras, rat primary astrocytes were transiently transfected with ⌬p21ras, and 24 h after transfection cells were stimulated with different combinations of
TNF-␣, IL-1␤, and IFN-␥. All the combinations of cytokines induced the production of NO significantly; however, the expression of ⌬p21ras potently inhibited the NO
production (Fig. 3A) and the induction of iNOS protein

⌬p21ras inhibits iNOS promoter-derived CAT
activity in cytokine-stimulated rat primary
astrocytes
Inhibition of the induction of iNOS protein and
mRNA in astrocytes by the expression of ⌬p21ras suggests that the knockdown of p21ras may inhibit the transcription of iNOS gene. Therefore, to understand the
effect of ⌬p21ras on the transcription of iNOS gene,
astrocytes were cotransfected with either ⌬p21ras or an
empty vector and piNOS-CAT, a construct containing
the iNOS promoter fused to the CAT gene, and activation of this promoter was measured after the cells were
stimulated with different cytokines. Consistent with the
effect of ⌬p21ras on the production of NO and the expression of endogenous iNOS protein and mRNA,

FIG. 2. Expression of ⌬p21ras inhibits the expression of iNOS
and production of NO in LPS-stimulated rat primary astrocytes.
Cells plated at 50 – 60% confluence in six-well plates were transfected with 2 g of either ⌬p21ras or an empty vector using
Lipotaxi as described in Materials and Methods. At 24 h after
transfection, cells were stimulated with 1 g/ml LPS. A: After
24 h of stimulation, the production of nitrite was measured in
supernatants using Griess reagent as mentioned in Materials
and Methods. Data are means ⫾ SD of three different experiments. B: Cell homogenates were electrophoresed, transferred
onto nitrocellulose membrane, and immunoblotted with antibodies against mouse macrophage iNOS as described in Materials
and Methods. C: Cells plated at 50 – 60% confluence in 100-mm
dishes were transfected with 8 g of either ⌬p21ras or an empty
vector using Lipotaxi. At 24 h after transfection, cells were stimulated with 1 g/ml LPS for 5 h. Cells were taken out directly by
adding Ultraspec-II RNA reagent (Biotecx Laboratories Inc.) to
the plates for isolation of total RNA, and northern blot analysis
for iNOS mRNA was carried out as described in Materials and
Methods.
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expression by ⌬p21ras is due to the inhibition of NF-B
activation.

FIG. 3. Effect of ⌬p21ras-mediated knockdown of p21ras on the
expression of iNOS in cytokine-stimulated rat primary astrocytes. Cells plated at 50 – 60% confluence in six-well plates were
transfected with 2 g of either ⌬p21ras or an empty vector using
Lipotaxi. At 24 h after transfection, cells were stimulated with
different combinations of proinflammatory cytokines for 24 h.
The production of nitrite was measured in supernatants (A). Data
are means ⫾ SD of three different experiments. Cell homogenates were analyzed for iNOS protein by an immunoblotting
technique (B). Concentrations of different stimuli were as follows: TNF-␣, 10 ng/ml; IL-1␤, 10 ng/ml; IFN-␥, 10 U/ml.

⌬p21ras markedly inhibited the induction of iNOS promoter-derived CAT activity in cytokine-stimulated astrocytes (Fig. 4), suggesting the conclusion that ⌬p21ras
inhibits the transcription of iNOS gene in astrocytes.
Expression of ⌬p21ras inhibits the activation of
NF-B in rat primary astrocytes
As the activation of NF-B is necessary for the transcription of iNOS gene (Xie et al., 1994; Nishiya et al.,
1995; Pahan et al., 1998a,b), to understand the basis of
⌬p21ras-mediated inhibition of iNOS expression, we examined the effect of ⌬p21ras on the activation of NF-B.
Treatment of astrocytes with 1 g/ml LPS resulted in the
activation of DNA-binding activity of NF-B (Fig. 5).
This gel shift assay detected a specific band in response
to LPS that was competed off by an unlabeled NF-B
probe, but not by an unlabeled AP-1 probe (Fig. 5A).
Expression of ⌬p21ras or the empty vector alone failed to
induce the DNA-binding activity of NF-B. However,
⌬p21ras markedly inhibited LPS-induced DNA-binding
activity of NF-B (Fig. 5B). We then tested the effect of
⌬p21ras on NF-B-dependent transcription of luciferase
in astrocytes in the presence or absence of different
cytokines, using the expression of luciferase from a
reporter construct, pNF-B Luc (Stratagene), as an assay
(Pahan et al., 1998b, 1999). Consistent with the effect of
⌬p21ras on the DNA-binding activity of NF-B, ⌬p21ras
also inhibited NF-B-dependent transcription of luciferase in astrocytes, whereas expression of the empty
vector had no effect on the transcriptional activity of
NF-B (Fig. 5C), suggesting that the inhibition of iNOS
J. Neurochem., Vol. 74, No. 6, 2000

Involvement of p21ras in the expression of iNOS in
human primary astrocytes
As in rat primary astrocytes, proinflammatory cytokines are also able to induce the production of nitrite, as
well as the expression of iNOS, in human primary astrocytes (Lee et al., 1993). To investigate whether p21ras
is also involved in the induction of iNOS in human
primary astrocytes, cells were transfected with ⌬p21ras.
Different combinations of proinflammatory cytokines induced the production of NO (Fig. 6A) and the expression
of iNOS protein (Fig. 6B), whereas the expression of
⌬p21ras alone had no effect on NO production. However,
⌬p21ras significantly inhibited cytokine-stimulated production of NO (Fig. 6A) and expression of iNOS protein
(Fig. 6B), suggesting that in both rat and human primary
astrocytes, the induction of iNOS requires the involvement of p21ras.
DISCUSSION
ras

p21 , a membrane-associated small guanine nucleotide-binding protein, plays a central role in transmitting
extracellular signals within the cell and in controlling
cellular proliferation and differentiation (Gomez et al.,
1998). Here we present evidence that activation of p21ras
is involved in the activation of NF-B and the induction
of iNOS in activated primary astrocytes. Our conclusion
is based on the following observations. First, LPS and

FIG. 4. Effect of ⌬p21ras-mediated knockdown of p21ras on
iNOS promoter-derived CAT activity in cytokine-stimulated rat
primary astrocytes. Cells plated at 50 – 60% confluence in sixwell plates were cotransfected with 1 g of piNOS-CAT (the
construct containing the rat iNOS promoter fused to the CAT
gene) and 2 g of either ⌬p21ras or an empty vector using
Lipotaxi. At 24 h after transfection, cells were stimulated with
LPS and proinflammatory cytokines for 14 h under serum-free
conditions. The activity of CAT was measured using the radioisotopic assay kit (Promega) following the manufacturer’s protocol. The concentrations of different stimuli were as follows:
LPS, 1.0 g/ml; TNF-␣, 10 ng/ml; IL-1␤, 10 ng/ml; IFN-␥, 10
U/ml.
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proinflammatory cytokines induced the GTP loading of
p21ras, the activation of NF-B, and the expression of
iNOS. Second, expression of a dominant-inhibitory mutant of p21ras (⌬p21ras) knocked down LPS- and cytokine-induced GTP loading of p21ras and inhibited LPSand cytokine-induced activation of NF-B and the expression of iNOS. These studies demonstrate that p21ras
is involved in the activation of NF-B and the induction
of iNOS in primary astrocytes. As NO synthesized from
iNOS has been implicated in the pathogenesis of demyelinating and neurodegenerative diseases (Koprowski
et al., 1993; Merrill et al., 1993; Cross et al., 1994;
Endoh et al., 1994; Schubert et al., 1998), our results
indicate that activation of p21ras may be a critical signaling step in the regulation of neuroinflammatory and
neurodegenerative diseases, and pharmacological compounds capable of counteracting the activation of p21ras
may ameliorate neural injury.
Signaling mechanisms for the induction of iNOS are
poorly understood. The presence of a consensus DNAbinding site for NF-B in the promoter of iNOS and
inhibition of the LPS-induced expression of iNOS by
inhibitors of NF-B activation suggest that LPS induces
the expression of these inflammatory molecules via activation of NF-B (Xie et al., 1994; Nishiya et al., 1995;
Pahan et al., 1998a,b). Earlier studies of Pahan et al.
(1997b) demonstrating the inhibition of NF-B activation and expression of iNOS by lovastatin and sodium
phenylacetate suggested a role of protein farnesylation in
the activation of NF-B and induction of inflammatory
molecules. Consistent with this observation, we demonstrate here the involvement of p21ras in the activation of
FIG. 5. Expression of ⌬p21ras inhibits the activation of NF-B in
LPS- and cytokine-stimulated rat primary astrocytes. A: Cells
incubated in serum-free medium were treated with 1 g/ml LPS.
After a 30-min incubation, cells were taken out to prepare nuclear extracts, and nuclear proteins were used for the EMSA as
described in Materials and Methods. Lane 1, nuclear extract of
control cells; lane 2, nuclear extract of LPS-treated cells; lane 3,
nuclear extract of LPS-treated cells incubated with a 100-fold
excess of unlabeled NF-B probe; and lane 4, nuclear extract of
LPS-treated cells incubated with a 100-fold excess of unlabeled
AP-1 probe. The upper arrow indicates the induced NF-B,
whereas the lower arrow indicates the unbound probe. B: Cells
plated at 50 – 60% confluence in six-well plates were transfected
with 2 g of either ⌬p21ras or an empty vector using Lipotaxi. At
24 h after transfection, cells received 1 g/ml LPS. After 30 min
of stimulation, EMSA for NF-B was carried out in nuclear extracts as described. Lane 1, nuclear extract of vector-transfected cells; lane 2, nuclear extract of ⌬p21ras-transfected cells;
lane 3, nuclear extract of vector-transfected cells treated with
LPS; and lane 4, nuclear extract of ⌬p21ras-transfected cells
treated with LPS. The upper arrow indicates the induced NF-B,
whereas the lower arrow indicates the unbound probe. C: Cells
plated at 50 – 60% confluence in six-well plates were cotransfected with 1 g of pNF-B-Luc (an NF-B-dependent reporter
construct) and 2 g of either ⌬p21ras or empty vector using
Lipotaxi. At 24 h after transfection, cells were stimulated with
LPS and cytokines for 4 h, and the expression of luciferase
reporter was quantified as described in Materials and Methods.
Data are means ⫾ SD of three different experiments. The concentrations of different stimuli were as follows: LPS, 1.0 g/ml;
TNF-␣, 10 ng/ml; IL-1␤, 10 ng/ml; IFN-␥, 10 U/ml.

FIG. 6. ⌬p21ras-mediated knockdown of p21ras inhibits the expression of iNOS and production of NO in human primary astrocytes. Cells plated at 50 – 60% confluence in six-well plates
were transfected with 2 g of either ⌬p21ras or an empty vector
using Lipotaxi. At 24 h after transfection, cells were stimulated
with different combinations of proinflammatory cytokines for
48 h. The production of nitrite was measured in supernatants (A).
Data are means ⫾ SD of three different experiments. Cell homogenates were analyzed for iNOS protein by an immunoblotting technique (B). The concentrations of different stimuli were
as follows: TNF-␣, 10 ng/ml; IL-1␤, 10 ng/ml; IFN-␥, 10 U/ml.
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NF-B and the induction of iNOS in LPS- and cytokinestimulated primary astrocytes. The Ras protooncogene
proteins, a family of GTP-binding proteins, function by
binding to the cytoplasmic surface of the plasma membrane. This membrane localization of p21ras involves
prenylation of cysteine in CAAX motif present at the
C-terminus, proteolytic removal of AAX tripeptide, and
then carboxymethylation of C-terminal cysteine (Hancock et al., 1991). The activation of p21ras by receptor
tyrosine kinase occurs through conversion of the GDPbound inactive form to the GTP-bound active form by
Sos and Grb2 and then transduction of signal to downstream effector molecules (Kikuchi and Williams, 1994).
The GTP-bound form is converted to the inactive form
by the intrinsic GTPase activity, which is accelerated by
GTPase-activating proteins (Boguski and McCormick,
1993). The mutated p21ras protein translated from the
expression of ⌬p21ras binds preferentially to GDP and
acts as the dominant inhibitor of p21ras function presumably by blocking access to exchange factors and, in turn,
inhibiting the signal transmission to the downstream
signaling molecules (Qiu et al., 1995; Garnovskaya et al.,
1996). One such downstream candidate is Raf-1 (serinethreonine kinase). p21ras interacts directly with Raf-1 and
is believed to function by positioning Raf-1 at the plasma
membrane in the vicinity of its activator, and tyrosine
phosphorylation of Raf-1 seems to be essential for
p21ras-induced activation of Raf-1 (Jelinek et al., 1996).
Raf-1, in turn, phosphorylates and activates MEKs and
ERKs (members of mitogen-activated protein kinase cascade). Therefore, the observed inhibition of NF-B activation and induction of iNOS by ⌬p21ras may be due to
decrease or lack of signal transmission from receptor
tyrosine kinase to Raf/mitogen-activated protein kinase
cascade via p21ras.
NO, a diffusible free radical, plays many roles as a
signaling and as an effector molecule in diverse biological systems, including neuronal messenger, vasodilation, and antimicrobial and antitumor activities (Nathan,
1992; Jaffrey and Snyder, 1995). In the nervous system,
the NO appears to have both neurotoxic and neuroprotective effects and may have a role in the pathogenesis of
stroke and other neurodegenerative diseases (e.g., Alzheimer’s disease) and in demyelinating conditions (e.g.,
multiple sclerosis, experimental allergic encephalopathy,
X-adrenoleukodystrophy) associated with the activation
of glial cells and the production of proinflammatory
cytokines (Koprowski et al., 1993; Merrill et al., 1993;
Cross et al., 1994; Endoh et al., 1994; Schubert et al.,
1998). NO and peroxynitrite (reaction product of NO and
O2⫺) are potentially toxic to neurons and oligodendrocytes that may mediate toxicity through the formation of
iron–NO complexes of iron-containing enzyme systems
(Drapier and Hibbs, 1988), oxidation of protein sulfhydryl groups (Radi et al., 1991), nitration of proteins,
nitrosylation of nucleic acids, and DNA strand breaks
(Wink et al., 1991). Although monocytes/macrophages
are the primary source of iNOS in inflammation, LPS
and other cytokines induce a similar response in astroJ. Neurochem., Vol. 74, No. 6, 2000

cytes and microglia (Simmons and Murphy, 1992;
Zielasek et al., 1992; Pahan et al., 1997b). NO derived
from activated microglia and astrocytes has been implicated in the damage of myelin-producing oligodendrocytes in demyelinating disorders like multiple sclerosis
and neuronal death during neurodegenerating conditions,
including brain trauma and Alzheimer’s disease (Koprowski et al., 1993; Merrill et al., 1993; Cross et al.,
1994; Endoh et al., 1994; Schubert et al., 1998). The
studies described in this article suggest that inhibition of
p21ras activation may represent a possible avenue of
research for therapeutics directed against cytokine- and
NO-mediated neuroinflammatory and neurodegenerative
disorders.
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